| GRGTX | VIVIX | GRGTX / VIVIX | |
| Total Expense Ratio | 0.74 | 0.04 | 1,850% |
| Annual Report Gross Expense Ratio | 0.94 | 0.04 | 2,350% |
| Fund Existence | 18 years | 28 years | - |
| Gain YTD | 4.595 | 5.999 | 77% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 431M | 218B | 0% |
| Annual Yield % from dividends | 1.31 | 1.96 | 67% |
| Returns for 1 year | 3.96 | 15.08 | 26% |
| Returns for 3 years | 19.69 | 41.04 | 48% |
| Returns for 5 years | 28.44 | 66.28 | 43% |
| Returns for 10 years | 102.55 | 167.19 | 61% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TRWCX | 25.79 | -0.01 | -0.04% |
| Transamerica International Equity C | |||
| KSCOX | 171.44 | -0.08 | -0.05% |
| Kinetics Small Cap Opportunities No Load | |||
| RYOAX | 59.77 | -0.08 | -0.13% |
| Rydex Biotechnology H | |||
| CNPAX | 70.41 | -0.89 | -1.25% |
| American Funds New Perspective 529A | |||
| TCPWX | 12.21 | -0.33 | -2.63% |
| Transamerica Capital Growth R6 | |||